Aiming to tackle the high risk of heart problems among older Americans with obesity, Medicare is contemplating an expansion of coverage for a weight-loss medication known as semaglutide.
Professor Shuenn-Yuh Lee, National Cheng Kung University, discusses his mission to build a user-friendly development platform with smart wearable technology, in this report.
Transcending morphology, magnetic resonance techniques can be utilised to shed light on processes on the molecular level to unveil pathological alterations preceding anatomical and functional manifestations of (cardiovascular) diseases, in the view of Ulrich Flögel from Heinrich Heine University Düsseldorf, Germany.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group explores the emerging role of tumour necrosis factor receptor-associated factor 6 including the challenges and opportunities in this vein.
Thomas Münzel MD, Andreas Daiber PhD, Ulrich Pöschl PhD and Jos Lelieveld PhD discuss the link between air pollution and cardiovascular disease in Europe.
Cardiovascular diseases are on the rise, but so is confusion as to how to prevent them. Shaun Ingram, MD of Cardiac Science takes a look at the data, shares his views and strikes a cautious note of optimism.
John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
In this interview, Chair of the ESC Digital Health Committee, Professor Martin Cowie, details the opportunities and challenges in the digital health era when it comes to the field of cardiovascular disease.
Cardiovascular magnetic resonance techniques can unveil metabolic alterations preceding anatomical and functional manifestations of diseases, the Department of Experimental Cardiovascular Imaging explains here.
Diseases could be detected even before people experience symptoms, thanks to a pioneering new health-data programme as part of the government’s modern Industrial Strategy.
Jeremy Hunt commits £70 million funding over three and a half years for the Better Health Programme, a range of health initiatives that could improve the lives of up to 150 million people across 8 emerging economies.
The University of Manchester found that patients with common lung diseases are substantially more likely to suffer a heart attack and develop other major heart problems.
Dr. Connolly, Consultant Interventional Cardiology, talks exclusively to Open Access Government about the NHS use of AI technology like Heartflow in the fight against coronary heart disease.
Thomas Münzel MD, Omar Hahad PhD and Andreas Daiber PhD discuss the link between noise and cardiovascular disease, in this report about their research in the field.
Cardiovascular disease claims the most lives every year but is largely preventable according to the President of the European Association of Preventive Cardiology, a branch of the European Society of Cardiology.
Professor Graham MacGregor, Chair of Action on Sugar, discusses stopping excessive sugar consumption, whilst investigating obesity and type 2 diabetes.
